Marc Ernstoff, MD

Marc S. Ernstoff, MD, provides recommendations for managing patients with metastatic melanoma.

Marc S. Ernstoff, MD, discusses why physicians would treat metastatic melanoma with immunotherapy prior to small molecule inhibitors in most cases.

Marc S. Ernstoff, MD, discusses metastatic melanoma and how patients may be managed.

Marc Ernstoff, MD, director of melanoma, Cleveland Clinic, discusses progression-free survival (PFS) and safety in patients with advanced melanoma (MEL) receiving nivolumab (NIVO) combined with ipilimumab (IPI).